References
- AKATSU, H., IWABUCHI, N., XIAO, J.-Z., MATSUYAMA, Z., KURIHARA, R., OKUDA, K., YAMAMOTO, T. & MARUYAMA, M. 2012. Clinical Effects of Probiotic Bifidobacterium longum BB536 on Immune Function and Intestinal Microbiota in Elderly Patients Receiving Enteral Tube Feeding. JPEN. Journal of parenteral and enteral nutrition, 37.
- ANDRADE, S. & BORGES, N. 2009. Effect of fermented milk containing Lactobacillus acidophilus and Bifidobacterium longum on plasma lipids of women with normal or moderately elevated cholesterol. The Journal of dairy research, 76, 469-74.
- BERTRAND, S., BOHNI, N., SCHNEE, S., SCHUMPP, O., GINDRO, K. & WOLFENDER, J.-L. 2014. Metabolite induction via microorganism co-culture: A potential way to enhance chemical diversity for drug discovery. Biotechnology advances, 32, 1180–1204.
- BO, C., SUN, L., ZENG, G., SHEN, Z., WANG, K., YIN, L., XU, F., WANG, P., DING, Y., NIE, Q., WU, Q., ZHANG, Z., XIA, J., LIN, J., LUO, Y., CAI, J., KRAUSZ, K., ZHENG, R., XUE, Y. & JIANG, C. 2022. Gut bacteria alleviate smoking-related NASH by degrading gut nicotine. Nature, 610, 562-568.
- BORDONI, A., AMARETTI, A., LEONARDI, A., BOSCHETTI, E., DANESI, F., MATTEUZZI, D., RONCAGLIA, L., RAIMONDI, S. & ROSSI, M. 2013. Cholesterol-lowering probiotics: In vitro selection and in vivo testing of bifidobacteria. Applied microbiology and biotechnology, 97.
- CHASSARD, C., DELMAS, E., LAWSON, P. A., & BERNALIER-DONADILLE, A. 2008. Bacteroides xylanisolvens sp. nov., a xylan-degrading bacterium isolated from human faeces. International journal of systematic and evolutionary microbiology, 58(4), 1008-1013.
- GIARDINA, S., SCILIRONI, C., MICHELOTTI, A., SAMUELE, A., BORELLA, F., DAGLIA, M. & MARZATICO, F. 2014. In Vitro Anti-Inflammatory Activity of Selected Oxalate-Degrading Probiotic Bacteria: Potential Applications in the Prevention and Treatment of Hyperoxaluria. Journal of food science, 79.
- GOERS, L., FREEMONT, P. & POLIZZI, K. 2014. Co-culture systems and technologies: taking synthetic biology to the next level. Journal of the Interface, 11(96), 20140065.
- HAO, M.-L., WANG, G.-Y., ZUO, X.-Q., QU, C.-J., YAO, B.-C. & WANG, D.-L. 2019. Gut microbiota: an overlooked factor that plays a significant role in osteoporosis. Journal of International Medical Research, 47, 030006051986002.
- JIANG, J., WU, C., ZHANG, C., ZHANG, Q., YU, L., ZHAO, J., ZHANG, H., NARBAD, A., CHEN, W. & ZHAI, Q. 2021. Strain-Specific Effects of Bifidobacterium longum on Hypercholesterolemic Rats and Potential Mechanisms. International Journal of Molecular Sciences, 22, 1305.
- KäMPFER, A., URBáN, P., GIORIA, S., KANASE, N., STONE, V. & KINSNER-OVASKAINEN, A. 2017. Development of an in vitro co-culture model to mimic the human intestine in healthy and diseased state. Toxicology in vitro, 45(Pt 1), 31–43.
- KATAOKA, K. 2016. The intestinal microbiota and its role in human health and disease. The Journal of Medical Investigation, 63, 27-37.
- KHAN, N., MAEZATO, Y., MCCLURE, R., BRISLAWN, C., MOBBERLEY, J., ISERN, N., CHRISLER, W., MARKILLIE, L. M., BARNEY, B., SONG, H.-S., NELSON, W. & BERNSTEIN, H. 2018. Phenotypic responses to interspecies competition and commensalism in a naturally-derived microbial co-culture. Scientific Reports, 8(1), 297.
- LAGIER, J.-C., DUBOURG, G., MILLION, M., CADORET, F., BILEN, M., FENOLLAR, F., LEVASSEUR, A., ROLAIN, J., FOURNIER, P.-E. & RAOULT, D. 2018. Culturing the human microbiota and culturomics. Nature Reviews Microbiology, 16, 540-550.
- LEE, S. A., LIM, J. Y., KIM, B. S., CHO, S. J., KIM, N. Y., KIM, O. B., & KIM, Y. 2015. Comparison of the gut microbiota profile in breast-fed and formula-fed Korean infants using pyrosequencing. Nutrition research and practice, 9(3), 242-248.
- LIU, B.-N., LIU, X.-T., LIANG, Z.-H. & WANG, J.-H. 2021. Gut microbiota in obesity. World Journal of Gastroenterology, 27, 3837-3850.
- LIU, Y., JIN, X., HONG, H., XIANG, L., JIANG, Q., MA, Y., CHEN, Z., CHENG, L., JIAN, Z., WEI, Z., AI, J., QI, S., SUN, Q., LI, H., LI, Y. & WANG, K. 2020. The relationship between gut microbiota and short chain fatty acids in the renal calcium oxalate stones disease. The FASEB Journal 34(8): 11200-11214.
- MOGNA, L., PANE, M., NICOLA, S. & RAITERI, E. 2014. Screening of Different Probiotic Strains for Their In Vitro Ability to Metabolise Oxalates: Any Prospective Use in Humans? Journal of clinical gastroenterology, 48 Suppl 1, S91-S95.
- OCHOA-REPáRAZ, J. & KASPER, L. 2016. The Second Brain: Is the Gut Microbiota a Link Between Obesity and Central Nervous System Disorders? Current obesity reports, 5(1), 51-64.
- QIAO, S., LI, C.-S., WANG, K., SUN, S., LIAO, M., LIU, C., ZHOU, N., MA, K., ZHANG, Y., CHEN, Y., LIU, S.-J. & LIU, H. 2020. Activation of a Specific Gut Bacteroides-Fo-late-Liver Axis Benefits for the Alleviation of Nonalcoholic Hepatic Steatosis. Cell Reports, 32(6), 108005.
- RINNINELLA E, CINTONI M, RAOUL P, LOPETUSO LR, SCALDAFERRI F, PULCINI G.2019. Food Components and Dietary Habits: keys for a Healthy Gut Microbiota Composition. Nutrients. 11(10), 2393.
- RODES, L., SAHA, S., TOMARO-DUCHESNEAU, C., & PRAKASH, S. 2014. Microencapsulated Bifidobacterium longum subsp. infantis ATCC 15697 favorably modulates gut microbiota and reduces circulating endotoxins in F344 rats. BioMed Research International, 602832.
- SMID, E. & LACROIX, C. 2012. Microbe-microbe interactions in mixed culture food fermentations. Current opinion in biotechnology, 24(2), 148-154.
- TAKAHASHI, N., KITAZAWA, H., SHIMOSATO, T., IWABUCHI, N., XIAO, J.-Z., IWATSUKI, K., KOKUBO, S. & SAITO, T. 2006. An immunostimulatory DNA sequence from a probiotic strain of Bifidobacterium longum inhibits IgE production in vitro. FEMS immunology and medical microbiology, 46(3), 461-469.
- Tian, L., Liu, Y., Xu, X., Jiao, P., Hu, G., Cui, Y., Chen, J., Ma, Y., Jin, X., Wang, K., & Sun, Q. (2022). Lactiplanti-bacillus plantarum J-15 reduced calcium oxalate kidney stones by regulating intestinal microbiota, metabolism, and inflammation in rats. FASEB journal, 36(6), e22340.
- VINALE, F., NICOLETTI, R., BORRELLI, F., MANGONI, A., PARISI, O., MARRA, R., LOMBARDI, N., LACATENA, F., GRAUSO, L., FINIZIO, S., LORITO, M. & WOO, S. 2017. Co-Culture of Plant Beneficial Microbes as Source of Bioactive Metabolites. Scientific Reports, 7(1), 14330.
- WONG, C. B., ODAMAKI, T. & XIAO, J.-Z. 2019. Beneficial effects of Bifidobacterium longum subsp. longum BB536 on human health: Modulation of gut microbiome as the principal action. Journal of Functional Foods, 54, 506-519.
- XIAO, J.-Z., KONDO, S., YANAGISAWA, N., TAKAHASHI, N., ODAMAKI, T., IWABUCHI, N., IWATSUKI, K., KOKUBO, S., TOGASHI, H., ENOMOTO, K. & ENOMOTO, T. 2006. Effect of probiotic Bifidobacterium longum BBS36 in relieving clinical symptoms and modulating plasma cytokine levels of Japanese cedar pollinosis during the pollen season. A randomized double-blind, placebo-controlled trial. Journal of investigational allergology & clinical immunology, 16(2): 86-93.
- XU, D., WANG, L. & DU, C. 2015. Progress in microbial co-culture - A review. Acta Microbiologica Sinica, 55(9): 1089-1096.
- YAO, S., ZHAO, Z., WANG, W. & LIU, X. 2021. Bifidobacterium Longum: Protection against Inflammatory Bowel Disease. Journal of Immunology Research, 8030297.
- YOO, J., GROER, M., DUTRA, S., SARKAR, A. & MCSKIMMING, D. 2020. Gut Microbiota and Immune System Interactions. Microorganisms, 8(10), 1587.
- ZAFAR, H., & SAIER JR, M. H. 2021. Gut Bacteroides species in health and disease. Gut Microbes, 13(1), 1848158.
- ZHANG, L., ZHANG, Z., XU, L. & ZHANG, X. 2021. Maintaining the Balance of Intestinal Flora through the Diet: Effective Prevention of Illness. Foods(10), 10, 2312.